P-359 Patients’ experiences with elective egg freezing (EEF) consent processes: best practices and recommendations for improving informed consent

IF 6 1区 医学 Q1 OBSTETRICS & GYNECOLOGY
K Hammond
{"title":"P-359 Patients’ experiences with elective egg freezing (EEF) consent processes: best practices and recommendations for improving informed consent","authors":"K Hammond","doi":"10.1093/humrep/deaf097.665","DOIUrl":null,"url":null,"abstract":"Study question What are the consent processes for patients undergoing EEF at Canadian fertility clinics, and do these patients feel adequately informed through existing consent processes? Summary answer EEF consent processes rely on an unstandardized patchwork of sources. 18 EEF patients felt adequately informed; all patients thought that consent processes could be improved. What is known already The use of EEF is on the rise. Scholars have argued that the aggressive marketing of EEF, along with the fact that it is not medically necessary, necessitates a heightened standard for informed consent. In particular, scholars have argued that EEF patients need clear honest information that not only makes success rates clear but also provides patients with essential information about risks, costs, and options for the future uses of genetic material. Despite this, little to no research has evaluated EEF consent processes and EEF patients’ perceptions of these processes. This study sought to fill this gap. Study design, size, duration This study comprised of: (1) qualitative semi-structured interviews (average 37 minutes) with 27 participants, over the age of 18, who had undergone at least one cycle of EEF at a Canadian fertility clinic. Interviews occurred between April 2023 and September 2024. (2) Consent materials were collected from 11 Canadian fertility clinics. In February 2024 all Canadian fertility clinics were contacted by email with a request for samples of consent forms and accompanying materials. Participants/materials, setting, methods Average participant age, at time of freezing eggs, was 35 (range: 21-40). Interviews took place over Zoom and were recorded, transcribed and analyzed through NVivo. Consent materials came from clinics across Canada. In addition to the 11 consent forms, accompanying materials included information packages, brochures, online materials, and videos. All consent materials were analyzed by the principal investigator and a research assistant according to seven elements of ethical standards of disclosure. Main results and the role of chance Consent processes vary significantly from clinic to clinic and rely on an unstandardized patchwork of materials. Some consent materials are very thorough, but most did not adhere to minimum standards of disclosure. There were 8 areas that were recurringly mentioned by participants (5+) as areas where they did not feel as though they were given adequate information. These were: (1) administration of hormone injections, (2) logistics of the egg retrieval, (3) subsequent procedures to use frozen eggs (e.g. IVF), (4) emotional risks and inconveniences, (5) egg storage (cost and location) (6) success rates at the clinic where they pursued EEF, (7) options for any unused eggs, and (8) possibility to freeze embryos. In terms of how information was given, best practices noted by participants included: thorough meeting with the physician, opportunity to ask questions after initial meeting, inclusion of explanatory videos, online platforms, tutorials with a nurse, and complimentary fertility counseling. Problems with delivery of information for consent were: feeling rushed, no time to ask questions, questions unanswered, “barebones overview” of steps, and explanation (rather than demonstration) for hormonal injections. Limitations, reasons for caution Findings may be limited by the smaller sample size. Additionally, these findings stem from Canada and usefulness to other jurisdictions may be impacted, to some extent, by local laws, regulations, and guidelines pertaining to healthcare consent processes. Wider implications of the findings This study provides insight into what information EEF patients are seeking, i.e. what information EEF patients need to have given informed consent. It illustrates best practices for EEF consent processes and provides recommendations on how to optimize these processes to ensure informed consent. Trial registration number No","PeriodicalId":13003,"journal":{"name":"Human reproduction","volume":"40 1","pages":""},"PeriodicalIF":6.0000,"publicationDate":"2025-06-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Human reproduction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/humrep/deaf097.665","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Study question What are the consent processes for patients undergoing EEF at Canadian fertility clinics, and do these patients feel adequately informed through existing consent processes? Summary answer EEF consent processes rely on an unstandardized patchwork of sources. 18 EEF patients felt adequately informed; all patients thought that consent processes could be improved. What is known already The use of EEF is on the rise. Scholars have argued that the aggressive marketing of EEF, along with the fact that it is not medically necessary, necessitates a heightened standard for informed consent. In particular, scholars have argued that EEF patients need clear honest information that not only makes success rates clear but also provides patients with essential information about risks, costs, and options for the future uses of genetic material. Despite this, little to no research has evaluated EEF consent processes and EEF patients’ perceptions of these processes. This study sought to fill this gap. Study design, size, duration This study comprised of: (1) qualitative semi-structured interviews (average 37 minutes) with 27 participants, over the age of 18, who had undergone at least one cycle of EEF at a Canadian fertility clinic. Interviews occurred between April 2023 and September 2024. (2) Consent materials were collected from 11 Canadian fertility clinics. In February 2024 all Canadian fertility clinics were contacted by email with a request for samples of consent forms and accompanying materials. Participants/materials, setting, methods Average participant age, at time of freezing eggs, was 35 (range: 21-40). Interviews took place over Zoom and were recorded, transcribed and analyzed through NVivo. Consent materials came from clinics across Canada. In addition to the 11 consent forms, accompanying materials included information packages, brochures, online materials, and videos. All consent materials were analyzed by the principal investigator and a research assistant according to seven elements of ethical standards of disclosure. Main results and the role of chance Consent processes vary significantly from clinic to clinic and rely on an unstandardized patchwork of materials. Some consent materials are very thorough, but most did not adhere to minimum standards of disclosure. There were 8 areas that were recurringly mentioned by participants (5+) as areas where they did not feel as though they were given adequate information. These were: (1) administration of hormone injections, (2) logistics of the egg retrieval, (3) subsequent procedures to use frozen eggs (e.g. IVF), (4) emotional risks and inconveniences, (5) egg storage (cost and location) (6) success rates at the clinic where they pursued EEF, (7) options for any unused eggs, and (8) possibility to freeze embryos. In terms of how information was given, best practices noted by participants included: thorough meeting with the physician, opportunity to ask questions after initial meeting, inclusion of explanatory videos, online platforms, tutorials with a nurse, and complimentary fertility counseling. Problems with delivery of information for consent were: feeling rushed, no time to ask questions, questions unanswered, “barebones overview” of steps, and explanation (rather than demonstration) for hormonal injections. Limitations, reasons for caution Findings may be limited by the smaller sample size. Additionally, these findings stem from Canada and usefulness to other jurisdictions may be impacted, to some extent, by local laws, regulations, and guidelines pertaining to healthcare consent processes. Wider implications of the findings This study provides insight into what information EEF patients are seeking, i.e. what information EEF patients need to have given informed consent. It illustrates best practices for EEF consent processes and provides recommendations on how to optimize these processes to ensure informed consent. Trial registration number No
P-359患者选择卵子冷冻(EEF)同意过程的经验:改善知情同意的最佳做法和建议
研究问题:在加拿大生育诊所接受EEF的患者的同意程序是什么?这些患者是否通过现有的同意程序获得了充分的信息?EEF同意过程依赖于各种来源的非标准化拼凑。18例EEF患者感觉信息充分;所有患者都认为同意程序可以改进。EEF的使用正在增加。学者们认为,EEF的积极营销,以及它在医学上没有必要的事实,有必要提高知情同意的标准。特别是,学者们认为,EEF患者需要明确诚实的信息,不仅使成功率明确,而且为患者提供有关风险、成本和未来使用遗传物质的选择的基本信息。尽管如此,很少甚至没有研究评估EEF同意过程和EEF患者对这些过程的看法。这项研究试图填补这一空白。研究设计、规模、持续时间本研究包括:(1)对27名参与者进行定性半结构化访谈(平均37分钟),参与者年龄在18岁以上,在加拿大生育诊所至少接受过一次EEF周期。采访发生在2023年4月至2024年9月之间。(2)收集加拿大11家生育诊所的知情同意书资料。2024年2月,通过电子邮件联系了所有加拿大生育诊所,要求提供同意书样本和随附材料。参与者/材料、环境、方法在冷冻卵子时,参与者的平均年龄为35岁(范围:21-40岁)。采访通过Zoom进行,并通过NVivo进行记录、转录和分析。同意书材料来自加拿大各地的诊所。除了11份同意书外,随附材料还包括信息包、小册子、在线材料和视频。所有同意材料由首席研究员和一名研究助理根据披露伦理标准的七个要素进行分析。主要结果和偶然同意过程的作用因诊所而异,并且依赖于未标准化的材料拼凑。一些同意材料非常详尽,但大多数都没有遵守披露的最低标准。有8个领域被参与者反复提到(5+),因为他们觉得自己没有得到足够的信息。这些是:(1)激素注射的管理,(2)取卵的后勤,(3)使用冷冻卵子的后续程序(例如试管婴儿),(4)情感风险和不便,(5)卵子储存(成本和地点)(6)他们寻求EEF的诊所的成功率,(7)任何未使用的卵子的选择,(8)冷冻胚胎的可能性。在如何提供信息方面,参与者注意到的最佳做法包括:与医生进行彻底的会面,在初次会面后提问的机会,包括解释性视频,在线平台,护士教程以及免费的生育咨询。告知同意信息的问题是:感觉很匆忙,没有时间问问题,问题没有答案,对步骤的“粗略概述”,以及对激素注射的解释(而不是演示)。研究结果可能受到样本量较小的限制。此外,这些调查结果来自加拿大,对其他司法管辖区的有用性可能在一定程度上受到与医疗保健同意流程相关的当地法律、法规和指导方针的影响。本研究提供了EEF患者正在寻求的信息,即EEF患者需要给予知情同意的信息。它说明了EEF同意流程的最佳实践,并就如何优化这些流程以确保知情同意提供了建议。试验注册号
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Human reproduction
Human reproduction 医学-妇产科学
CiteScore
10.90
自引率
6.60%
发文量
1369
审稿时长
1 months
期刊介绍: Human Reproduction features full-length, peer-reviewed papers reporting original research, concise clinical case reports, as well as opinions and debates on topical issues. Papers published cover the clinical science and medical aspects of reproductive physiology, pathology and endocrinology; including andrology, gonad function, gametogenesis, fertilization, embryo development, implantation, early pregnancy, genetics, genetic diagnosis, oncology, infectious disease, surgery, contraception, infertility treatment, psychology, ethics and social issues.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信